SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-21-005035
Filing Date
2021-11-01
Accepted
2021-11-01 17:05:03
Documents
1
Period of Report
2021-11-01

Document Format Files

Seq Description Document Type Size
1 form4-11012021_021155.html 4  
1 form4-11012021_021155.xml 4 3099
  Complete submission text file 0001415889-21-005035.txt   4489
Mailing Address C/O TONIX PHARMACEUTICALS HOLDING CORP 509 MADISON AVE., SUITE 306 NEW YORK NY 10022
Business Address
MATHER CHARLES E IV (Reporting) CIK: 0001563422 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38365 | Film No.: 211368064

Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Issuer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations